title: [Clinical Practice Guidelines 2004. Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach: radiotherapy (therapeutic evaluation)].
abstract: BACKGROUND
  The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French regional cancer centers, and specialists from French Public Universities, General Hospitals and Private Clinics. The main objective is the development of clinical practice guidelines to improve the quality of health care and the outcome of cancer patients.
  
  
  OBJECTIVE
  To elaborate clinical practice guidelines for patients with stomach adenocarcinoma. These recommendations cover the diagnosis, treatment and follow-up of these tumors.
  
  
  METHODS
  The methodology is based on a literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery. The Standards, Options and Recommendations are thus based on the best available evidence and expert agreement.
  
  
  RESULTS
  This guidelines presents the synthesis of the data concerning the evaluation of the therapeutic ones. The main questions concern the type of gastrectomy to realize (Total Gastrectomy or gastrectomy subtotal), the extent of the lymphadenectomy (D2, D3 versus D1, D3, D2 versus D4) and the role of postoperative chemotherapy and adjuvant concomitant chemoradiotherapy.
authors.affiliation: Centre Val d'Aurelle, Montpellier.
authors.forename: Marc
authors.initials: M
authors.lastname: Ychou
authors.forename: Guillaume
authors.initials: G
authors.lastname: Gory-Delabaere
authors.forename: Pierre
authors.initials: P
authors.lastname: Blanc
authors.forename: Lise
authors.initials: L
authors.lastname: Bosquet
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Duffour
authors.forename: Marc
authors.initials: M
authors.lastname: Giovannini
authors.forename: François
authors.initials: F
authors.lastname: Guillemin
authors.forename: Claire
authors.initials: C
authors.lastname: Lemanski
authors.forename: Frédéric
authors.initials: F
authors.lastname: Marchal
authors.forename: Bruno
authors.initials: B
authors.lastname: Masson
authors.forename: Yacine
authors.initials: Y
authors.lastname: Merrouche
authors.forename: Geneviève
authors.initials: G
authors.lastname: Monges
authors.forename: Antoine
authors.initials: A
authors.lastname: Adenis
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bosset
authors.forename: Olivier
authors.initials: O
authors.lastname: Bouché
authors.forename: Thierry
authors.initials: T
authors.lastname: Conroy
authors.forename: Denis
authors.initials: D
authors.lastname: Pezet
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Triboulet
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods / Q000592:standards; D005743:Gastrectomy / Q000379:methods / Q000592:standards; D015391:Gastroplasty / Q000379:methods / Q000592:standards; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods / Q000592:standards; D010166:Palliative Care / Q000379:methods / Q000592:standards; D018714:Radiotherapy, Adjuvant / Q000379:methods / Q000592:standards; D016032:Randomized Controlled Trials as Topic; D013156:Splenectomy / Q000379:methods / Q000592:standards; D013274:Stomach Neoplasms / Q000532:radiotherapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents